The largest database of trusted experimental protocols

E coli bl21 de3 plyss

Manufactured by Transgene
Sourced in China

E. coli BL21(DE3)pLysS is a bacterial strain commonly used in molecular biology laboratories. It is a derivative of the E. coli BL21 strain, which is designed for efficient protein expression. The pLysS plasmid in this strain provides an additional control mechanism for protein expression, making it suitable for the production of recombinant proteins.

Automatically generated - may contain errors

4 protocols using e coli bl21 de3 plyss

1

Bgl1A(A24S/F297Y) production protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The strains and plasmids used in this study were listed in additional file (Additional file 1: Table S1). E. coli Trans5α (TransGen, Beijing, China) was used for plasmid construction. E. coli BL21(DE3) and E. coli BL21(DE3)pLysS (TransGen, Beijing, China) were used as the hosts for Bgl1A(A24S/F297Y) production. Ampicillin, chloramphenicol, and IPTG were purchased from Sangon Biotech (Shanghai, China). p-Nitrophenyl β-D-glucopyranoside (pNPG) was from Sigma-Aldrich (St. Louis, MO, USA). The insoluble microcrystalline cellulose with an average particle size of 25 μm was acquired from Aladdin Chemistry (Shanghai, China). Ni2+-charged chelating sepharose fast flow was purchased from GE Healthcare (Uppsala, Sweden). All other chemicals were of analytical grade unless otherwise specified. Standard TB medium (per liter contains 4 g glycerol, 24 g yeast extract, 12 g peptone, 17 mM KH2PO4, and 72 mM K2HPO4) was used as culture medium in 250-mL Erlenmeyer flasks. Modified TB medium (per liter contains 15 g glycerol) was employed in high cell density culture (HCDC), the feeding solutions contained 45 g tryptone, 45 g yeast extract, and 500 g glycerol per liter.
+ Open protocol
+ Expand
2

Recombinant Protein Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA sequences encoding the cytoplasmic domain of BAK1, mBAK1 (L317E), SERK5 and SlBIR3 were amplified by PCR and subcloned into the pFLAG-MAC vector (Sigma-Aldrich Saint Louis, MO, USA). The primers used are listed in Table S1. Each of the resulting constructs was transformed into E. coli BL21(DE3)pLysS (Transgene, Beijing, China). The resulting recombinant proteins were purified as previously described and the autophosphorylation and their transphosphorylation activities in vitro were determined as previously described [77 (link)], using anti-FLAG (1:5000) (Transgene, Beijing, China, Cat. #HT201-01) and anti-pThr (1:2000) (CST, Danvers, MA, USA, Cat. #93815) antisera.
+ Open protocol
+ Expand
3

Synthesis and Production of VHH against TBBPA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The synthesis of haptens of TBBPA and production of VHH against TBBPA were described in previous report (Wang et al., 2014 (link)). The pLIP6/GN vector containing AP gene used was a gift from Dr. Frédéric Ducancel from Pharmacology and Immunoanalysis Department, CEA/Saclay, Gif-sur-Yvette, France. The restriction enzymes SfiI and NotI and T4 DNA ligase were obtained from Thermo Fisher Scientific (Thermo, USA). The chemically competent cells of E.coli BL21 (DE3) pLysS and His-tag antibody-HRP were from Transgene Biotech (Guangzhou, China) was used for expression of the antibody fusion protein. The fluorescent substrate (2′-[2-benzothiazoyl]-6′-hydroxybenzothiazole phosphate, BBTP) was obtained from Promega (WI, USA). Standards were purchased from TCI Co. Ltd. (Tokyo, Japan) and other TBBPA analogues were purchased from AccuStandard (New Haven, CT). All other reagents were of analytical grade and purchased from Qixiang Technology Co., Ltd. (Guangzhou, China).
+ Open protocol
+ Expand
4

Recombinant Protein Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Deg-CarE ORF with restriction sites was amplified by PCR using specific primer sequences containing restriction endonuclease recognition sites (Table 1). The purified amplicons were ligated into pET-28a (+) and transformed into E. coli BL21 (DE3) pLysS (TransGen Biotech). A final concentration of 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added to the medium to induce protein expression when the optical density at 600 nm (OD600) of the bacterial solution was approximately 0.5–0.6. Subsequently, the bacterial suspension was collected at 24 h and lysed by ultrasonication. The protein was purified from insoluble bodies using ProteinIso Ni-NTA Resin (TransGen Biotech). The purified recombinant protein was analyzed by 10% SDS-PAGE. The resolved proteins were transferred to a polyvinylidene fluoride membrane, and immunoblotting with monoclonal antibody to His (ComWin Biotech Co., Ltd., Beijing, China) was performed to confirm the presence of the His-tagged proteins. The concentration of recombinant protein was determined by BCA assay (Solarbio Life Science, Beijing, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!